These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9293462)

  • 1. Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo.
    Wolff JE; Mölenkamp G; Hotfilder M; Laterra J
    Klin Padiatr; 1997; 209(4):275-7. PubMed ID: 9293462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiogenesis induced by rat glioma cells in vitro].
    Niida H; Minakawa T; Tanaka R
    No Shinkei Geka; 1992 Nov; 20(11):1169-72. PubMed ID: 1280347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
    Saleh M; Stacker SA; Wilks AF
    Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
    Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion.
    Grobben B; De Deyn PP; Slegers H
    Cell Tissue Res; 2002 Dec; 310(3):257-70. PubMed ID: 12457224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
    Tanaka T; Cao Y; Folkman J; Fine HA
    Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo.
    Ciafrè SA; Barillari G; Bongiorno-Borbone L; Wannenes F; Izquierdo M; Farace MG
    Gene Ther; 2002 Feb; 9(4):297-302. PubMed ID: 11896469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous growth inhibition of angiogenesis in brain tumors.
    Kirsch M; Allende R; Black P; Schackert G
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):469-79. PubMed ID: 17960325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain.
    Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C
    Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
    Brockmann MA; Papadimitriou A; Brandt M; Fillbrandt R; Westphal M; Lamszus K
    Clin Cancer Res; 2003 Oct; 9(12):4578-85. PubMed ID: 14555533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of angiogenesis and growth of malignant gliomas in the athymic nude rat model: immunotherapy against "basic fibroblast growth factor"].
    Nemati MN; Stan AC; Pütz KM; Pietsch T; Walter GF; Dietz H
    Zentralbl Neurochir; 1996; 57(1):12-9. PubMed ID: 8900894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
    Heiss JD; Papavassiliou E; Merrill MJ; Nieman L; Knightly JJ; Walbridge S; Edwards NA; Oldfield EH
    J Clin Invest; 1996 Sep; 98(6):1400-8. PubMed ID: 8823305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
    Bian XW; Jiang XF; Chen JH; Bai JS; Dai C; Wang QL; Lu JY; Zhao W; Xin R; Liu MY; Shi JQ; Wang JM
    Int Immunopharmacol; 2006 Jan; 6(1):90-9. PubMed ID: 16332517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy.
    Kruse CA; Visonneau S; Kleinschmidt-DeMasters BK; Gup CJ; Gomez GG; Paul DB; Santoli D
    Cancer Res; 2000 Oct; 60(20):5731-9. PubMed ID: 11059767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis.
    Winkler F; Kienast Y; Fuhrmann M; Von Baumgarten L; Burgold S; Mitteregger G; Kretzschmar H; Herms J
    Glia; 2009 Sep; 57(12):1306-15. PubMed ID: 19191326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.
    Abe T; Okamura K; Ono M; Kohno K; Mori T; Hori S; Kuwano M
    J Clin Invest; 1993 Jul; 92(1):54-61. PubMed ID: 7686924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.